Verrica Pharmaceuticals (VRCA) Interest & Investment Income (2018 - 2026)
Verrica Pharmaceuticals' Interest & Investment Income came in at $111,000 for Q2 2026, down 51.3% from $228,000 a year earlier and down 44.8% from the prior quarter.
Verrica Pharmaceuticals (VRCA) Interest & Investment Income (2018 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Verrica Pharmaceuticals reported Interest & Investment Income of $676,000, down 31.8% year-over-year; for FY2025, it came in at $929,000, down 34.4% from FY2024.
- Interest & Investment Income carries a five-year compound annual growth rate of 12.3% (FY2020 to FY2025).
- Going back by year, Interest & Investment Income was $1.42 million in FY2024 (-48.3%), $2.74 million in FY2023 (+475.6%), $476,000 in FY2022 (+287.0%) and $123,000 in FY2021 (-76.4%).
- The Q2 2026 figure represents the lowest quarterly Interest & Investment Income since Q2 2022.
- The fastest year-over-year change in Interest & Investment Income over five years came in Q4 2022 (growth of 959.3%), and the weakest in Q4 2024 (a decline of 74.1%).
- Business Quant data shows VRCA's Interest & Investment Income at $201,000 (Q1 2026), $205,000 (Q4 2025) and $159,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 219.00 Mn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 80.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Verrica Pharmaceuticals | 75.24 Mn | -7.80 Mn | - | 111,000.00 |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 111,000.00 |
| Mar 31, 2026 | 201,000.00 |
| Dec 31, 2025 | 205,000.00 |
| Sep 30, 2025 | 159,000.00 |
| Jun 30, 2025 | 228,000.00 |
| Mar 31, 2025 | 337,000.00 |
| Dec 31, 2024 | 205,000.00 |
| Sep 30, 2024 | 221,000.00 |
| Jun 30, 2024 | 393,000.00 |
| Mar 31, 2024 | 598,000.00 |
| Dec 31, 2023 | 792,000.00 |
| Sep 30, 2023 | 822,000.00 |
| Jun 30, 2023 | 626,000.00 |
| Mar 31, 2023 | 500,000.00 |
| Dec 31, 2022 | 286,000.00 |
| Sep 30, 2022 | 148,000.00 |
| Jun 30, 2022 | 20,000.00 |
| Mar 31, 2022 | 22,000.00 |
| Dec 31, 2021 | 27,000.00 |
| Sep 30, 2021 | 31,000.00 |
Verrica Pharmaceuticals Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=VRCA&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "VRCA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=VRCA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();